Search

everythinglearnresearchcommunity

for

Search:↓

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.

Men with early hair loss may have higher risks of insulin resistance and metabolic issues.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Non-immune factors play a significant role in alopecia areata.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Taxol damages hair growth cells, causing hair loss.